Sriyans Jain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sriyans Jain has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Ranjan Sen
Laboratory of Transcription, Centre for DNA Fingerprinting and Diagnostics, Inner Ring Road, Uppal, Hyderabad 500039, India
6 shared publications - Abhijeet Behera
Laboratory of Transcription, Centre for DNA Fingerprinting and Diagnostics, Inner Ring Road, Uppal, Hyderabad 500039, India
2 shared publications Pankaj V. Sharma
Laboratory of Transcription, Center for DNA Fingerprinting and Diagnostics, Hyderabad, India; Graduate Studies, Manipal Academy of Higher Education, Manipal, Karnataka, India
2 shared publications- Rahul Shubhra Mandal
Biomedical Informatics Center, National Institute of Cholera and Enteric Diseases, Kolkata, India
2 shared publications - Souvik Maiti
CSIR-Institute of Genomics & Integrative Biology, Mathura Road, Delhi 110025, India
2 shared publications Srinivasan Ramachandran
2 shared publications
Latest Publications
- Open Access
- 14 May 2026
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 483 (6) , 927-944
Functional interaction surfaces of the bacterial transcription terminator Rho are required for the interactions with the elongation factor NusG
Transcription terminator Rho interacts with the elongation factor NusG to induce efficient termination. By employing random mutagenesis, structure-guided site-directed mutagenesis, and phenotypic re-evaluations of our laboratory mutants, we identified several mutations in the Rho-linker region (∼135–155) and the hydrophobic pocket (200–230), in addition to those observed in the C-terminal domain (CTD) region (>250). These mutants exhibited synthetic growth defects and in vivo termination defects in the presence of the NusG-CTD mutant G146D, which is defective for Rho binding. Mutants from the Rho-CTD (I382A and I382N) were the most defective for NusG binding; however, mutants from the linker (E148R) and hydrophobic pocket (P167L) were also significantly impaired. These mutants did not respond properly to NusG in the in vitro transcription reactions. Fluorescence quenching assays showed that in presence of NusG, single-cysteine derivatives at 166C (near the linker), 202C (hydrophobic pocket), and at 325C (Rho-CTD) were buried from the surface, whereas that at 80C remained exposed to the solvent. A unique mutation of Rho, H256Y, residing near the Rho-hydrophobic patch defined the pathway of Rho-CTD to its N-terminal domain (NTD) conformational changes upon binding to NusG. We propose that NusG-CTD–Rho-CTD induces a conformational change pathway to the latter’s NTD to accelerate Rho-closed complex formation upon binding to the Rho utilisation sites.
- 14 May 2026
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 483 (6) , 927-944
Open AccessFunctional interaction surfaces of the bacterial transcription terminator Rho are required for the interactions with the elongation factor NusG
Transcription terminator Rho interacts with the elongation factor NusG to induce efficient termination. By employing random mutagenesis, structure-guided site-directed mutagenesis, and phenotypic re-evaluations of our laboratory mutants, we identified several mutations in the Rho-linker region (∼135–155) and the hydrophobic pocket (200–230), in addition to those observed in the C-terminal domain (CTD) region (>250). These mutants exhibited synthetic growth defects and in vivo termination defects in the presence of the NusG-CTD mutant G146D, which is defective for Rho binding. Mutants from the Rho-CTD (I382A and I382N) were the most defective for NusG binding; however, mutants from the linker (E148R) and hydrophobic pocket (P167L) were also significantly impaired. These mutants did not respond properly to NusG in the in vitro transcription reactions. Fluorescence quenching assays showed that in presence of NusG, single-cysteine derivatives at 166C (near the linker), 202C (hydrophobic pocket), and at 325C (Rho-CTD) were buried from the surface, whereas that at 80C remained exposed to the solvent. A unique mutation of Rho, H256Y, residing near the Rho-hydrophobic patch defined the pathway of Rho-CTD to its N-terminal domain (NTD) conformational changes upon binding to NusG. We propose that NusG-CTD–Rho-CTD induces a conformational change pathway to the latter’s NTD to accelerate Rho-closed complex formation upon binding to the Rho utilisation sites.
- Open Access
- 31 January 2025
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 482 (03) , 103-117
DNA binding of an RNA helicase bacterial transcription terminator
The bacterial transcription terminator Rho is a hexameric ATP-dependent RNA helicase that dislodges elongating RNA polymerases. It has an N-terminal primary RNA binding site (PBS) on each subunit and a C-terminal secondary RNA binding site at the central channel. Here, we show that Rho also binds to linear longer double-stranded DNAs (dsDNAs) and the circular plasmids nonspecifically using its PBS. However, this interaction could be competed efficiently by single-stranded DNA (ssDNA), dC34. Long dsDNA (3.5 kb) at the PBS activates short oligo C RNA-mediated ATPase activity at the secondary binding site (SBS). The pre-bound Rho to this long DNA reduces the rate and efficiency of its transcription termination activities in vitro. Elevated concentrations of Rho reduced the in vitro transcription level suggesting that Rho might also function as a nonspecific repressor of gene expression under certain conditions. In the mid-log phase culture, Rho molecules were concentrated at the poles and along the membrane. In contrast, the Rho hexamers were observed to be distributed over the bacterial chromosome in the stationary phase likely in a hyper-oligomeric state composed of oligomers of hexamers. We propose that Rho molecules not engaged in the transcription termination process could use the bacterial chromosome as a “resting surface”. This way the “idle” DNA-bound Rho molecules could be kept away from accidentally loading onto the nascent RNA and initiating unwanted transcription termination.
- 31 January 2025
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 482 (03) , 103-117
Open AccessDNA binding of an RNA helicase bacterial transcription terminator
The bacterial transcription terminator Rho is a hexameric ATP-dependent RNA helicase that dislodges elongating RNA polymerases. It has an N-terminal primary RNA binding site (PBS) on each subunit and a C-terminal secondary RNA binding site at the central channel. Here, we show that Rho also binds to linear longer double-stranded DNAs (dsDNAs) and the circular plasmids nonspecifically using its PBS. However, this interaction could be competed efficiently by single-stranded DNA (ssDNA), dC34. Long dsDNA (3.5 kb) at the PBS activates short oligo C RNA-mediated ATPase activity at the secondary binding site (SBS). The pre-bound Rho to this long DNA reduces the rate and efficiency of its transcription termination activities in vitro. Elevated concentrations of Rho reduced the in vitro transcription level suggesting that Rho might also function as a nonspecific repressor of gene expression under certain conditions. In the mid-log phase culture, Rho molecules were concentrated at the poles and along the membrane. In contrast, the Rho hexamers were observed to be distributed over the bacterial chromosome in the stationary phase likely in a hyper-oligomeric state composed of oligomers of hexamers. We propose that Rho molecules not engaged in the transcription termination process could use the bacterial chromosome as a “resting surface”. This way the “idle” DNA-bound Rho molecules could be kept away from accidentally loading onto the nascent RNA and initiating unwanted transcription termination.
- Open Access
- 20 October 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (12) , 105373
Peptides designed from a bacteriophage capsid protein function as synthetic transcription repressors
- 20 October 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (12) , 105373
Open AccessPeptides designed from a bacteriophage capsid protein function as synthetic transcription repressors
- Open Access
- 1 January 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 296, 100653
Design of novel peptide inhibitors against the conserved bacterial transcription terminator, Rho
- 1 January 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 296, 100653
Open AccessDesign of novel peptide inhibitors against the conserved bacterial transcription terminator, Rho
- 1 December 2019
- Published by Elsevier in Journal of Molecular Biology
- Vol. 431 (24) , 4749-4766
Vibrio cholerae YaeO is a Structural Homologue of RNA Chaperone Hfq that Inhibits Rho-dependent Transcription Termination by Dissociating its Hexameric State
- 1 December 2019
- Published by Elsevier in Journal of Molecular Biology
- Vol. 431 (24) , 4749-4766
Vibrio cholerae YaeO is a Structural Homologue of RNA Chaperone Hfq that Inhibits Rho-dependent Transcription Termination by Dissociating its Hexameric State
- Open Access
- 14 March 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1207
Rho-dependent transcription termination in bacteria recycles RNA polymerases stalled at DNA lesions
In bacteria, transcription-coupled repair of DNA lesions initiates after the Mfd protein removes RNA polymerases (RNAPs) stalled at the lesions. The bacterial RNA helicase, Rho, is a transcription termination protein that dislodges the elongation complexes. Here, we show that Rho dislodges the stalled RNAPs at DNA lesions. Strains defective in both Rho and Mfd are susceptible to DNA-damaging agents and are inefficient in repairing or propagating UV-damaged DNA. In vitro transcription assays show that Rho dissociates the stalled elongation complexes at the DNA lesions. We conclude that Rho-dependent termination recycles stalled RNAPs, which might facilitate DNA repair and other DNA-dependent processes essential for bacterial cell survival. We surmise that Rho might compete with, or augment, the Mfd function.
- 14 March 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1207
Open AccessRho-dependent transcription termination in bacteria recycles RNA polymerases stalled at DNA lesions
In bacteria, transcription-coupled repair of DNA lesions initiates after the Mfd protein removes RNA polymerases (RNAPs) stalled at the lesions. The bacterial RNA helicase, Rho, is a transcription termination protein that dislodges the elongation complexes. Here, we show that Rho dislodges the stalled RNAPs at DNA lesions. Strains defective in both Rho and Mfd are susceptible to DNA-damaging agents and are inefficient in repairing or propagating UV-damaged DNA. In vitro transcription assays show that Rho dissociates the stalled elongation complexes at the DNA lesions. We conclude that Rho-dependent termination recycles stalled RNAPs, which might facilitate DNA repair and other DNA-dependent processes essential for bacterial cell survival. We surmise that Rho might compete with, or augment, the Mfd function.
- Open Access
- 4 May 2016
- Published by Taylor & Francis in RNA Biology
- Vol. 14 (5) , 522-535
Long non-coding RNA: Functional agent for disease traits
In recent years, long non-coding RNAs (lncRNAs) have attracted the attention of researchers with their involvement in all facets of life. LncRNAs are transcripts of more than 200 nucleotides which lack defined protein coding potential. Although they do not code for proteins, a large number of them are involved in regulating gene expression and translation. The presence of numerous lncRNAs in the human genome has prompted us to investigate the contribution of these molecules to human biology and medicine. In this review, we present the potential role of lncRNAs interlinked to different human diseases and genetic disorders. We also describe their role in cellular differentiation and aging and discuss their potential importance as biomarkers and as therapeutic agents.
- 4 May 2016
- Published by Taylor & Francis in RNA Biology
- Vol. 14 (5) , 522-535
Open AccessLong non-coding RNA: Functional agent for disease traits
In recent years, long non-coding RNAs (lncRNAs) have attracted the attention of researchers with their involvement in all facets of life. LncRNAs are transcripts of more than 200 nucleotides which lack defined protein coding potential. Although they do not code for proteins, a large number of them are involved in regulating gene expression and translation. The presence of numerous lncRNAs in the human genome has prompted us to investigate the contribution of these molecules to human biology and medicine. In this review, we present the potential role of lncRNAs interlinked to different human diseases and genetic disorders. We also describe their role in cellular differentiation and aging and discuss their potential importance as biomarkers and as therapeutic agents.
- 1 December 2013
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1834 (12) , 2736-2749
Probing the amino acids critical for protein oligomerisation and protein–nucleotide interaction in Mycobacterium tuberculosis PII protein through integration of computational and experimental approaches
- 1 December 2013
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1834 (12) , 2736-2749
Probing the amino acids critical for protein oligomerisation and protein–nucleotide interaction in Mycobacterium tuberculosis PII protein through integration of computational and experimental approaches
- 1 July 2013
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 96 (7) , 4142-4148
Capsicum annuum enhances l-lactate production by Lactobacillus acidophilus: Implication in curd formation
Lactobacillus acidophilus is commonly used lactic acid bacteria for producing fermented milk products. In general household practice, curdling is known to occur faster in the presence of red chili. Herein we analyzed the enhanced effect of red chili (Capsicum annuum) and its major component, capsaicin, on Lactobacillus acidophilus (ATCC 4356) in the production of L-lactate in de Man, Rogosa, and Sharpe medium at various temperatures (15, 20, 25, 30, and 37°C). The addition of red chili showed significant increase in the amount of L-lactate produced by L. acidophilus compared with the control at all temperatures. Similar results were observed with addition of capsaicin alone. This was accompanied by an increase in the consumption of d-glucose. Capsazepine, a known antagonist of capsaicin, inhibited the production of L-lactate by L. acidophilus in the presence of both capsaicin and red chili. Because no increase occurred in the growth of L. acidophilus in the presence of red chili, the enhanced production of L-lactate in the presence of red chili or capsaicin is due to increased metabolic activity.
- 1 July 2013
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 96 (7) , 4142-4148
Capsicum annuum enhances l-lactate production by Lactobacillus acidophilus: Implication in curd formation
Lactobacillus acidophilus is commonly used lactic acid bacteria for producing fermented milk products. In general household practice, curdling is known to occur faster in the presence of red chili. Herein we analyzed the enhanced effect of red chili (Capsicum annuum) and its major component, capsaicin, on Lactobacillus acidophilus (ATCC 4356) in the production of L-lactate in de Man, Rogosa, and Sharpe medium at various temperatures (15, 20, 25, 30, and 37°C). The addition of red chili showed significant increase in the amount of L-lactate produced by L. acidophilus compared with the control at all temperatures. Similar results were observed with addition of capsaicin alone. This was accompanied by an increase in the consumption of d-glucose. Capsazepine, a known antagonist of capsaicin, inhibited the production of L-lactate by L. acidophilus in the presence of both capsaicin and red chili. Because no increase occurred in the growth of L. acidophilus in the presence of red chili, the enhanced production of L-lactate in the presence of red chili or capsaicin is due to increased metabolic activity.
- 1 January 2013
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 31 (1) , 30-43
Computational screening for new inhibitors ofM. tuberculosismycolyltransferases antigen 85 group of proteins as potential drug targets
The group of antigen 85 proteins of Mycobacterium tuberculosis is responsible for converting trehalose monomycolate to trehalose dimycolate, which contributes to cell wall stability. Here, we have used a serial enrichment approach to identify new potential inhibitors by searching the libraries of compounds using both 2D atom pair descriptors and binary fingerprints followed by molecular docking. Three different docking softwares AutoDock, GOLD, and LigandFit were used for docking calculations. In addition, we applied the criteria of selecting compounds with binding efficiency close to the starting known inhibitor and showing potential to form hydrogen bonds with the active site amino acid residues. The starting inhibitor was ethyl-3-phenoxybenzyl-butylphosphonate, which had IC50 value of 2.0 μM in mycolyltransferase inhibition assay. Our search from more than 34 million compounds from public libraries yielded 49 compounds. Subsequently, selection was restricted to compounds conforming to the Lipinski rule of five and exhibiting hydrogen bonding to any of the amino acid residues in the active site pocket of all three proteins of antigen 85A, 85B, and 85C. Finally, we selected those ligands which were ranked top in the table with other known decoys in all the docking results. The compound NIH415032 from tuberculosis antimicrobial acquisition and coordinating facility was further examined using molecular dynamics simulations for 10 ns. These results showed that the binding is stable, although some of the hydrogen bond atom pairs varied through the course of simulation. The NIH415032 has antitubercular properties with IC90 at 20 μg/ml (53.023 μM). These results will be helpful to the medicinal chemists for developing new antitubercular molecules for testing.
- 1 January 2013
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 31 (1) , 30-43
Computational screening for new inhibitors ofM. tuberculosismycolyltransferases antigen 85 group of proteins as potential drug targets
The group of antigen 85 proteins of Mycobacterium tuberculosis is responsible for converting trehalose monomycolate to trehalose dimycolate, which contributes to cell wall stability. Here, we have used a serial enrichment approach to identify new potential inhibitors by searching the libraries of compounds using both 2D atom pair descriptors and binary fingerprints followed by molecular docking. Three different docking softwares AutoDock, GOLD, and LigandFit were used for docking calculations. In addition, we applied the criteria of selecting compounds with binding efficiency close to the starting known inhibitor and showing potential to form hydrogen bonds with the active site amino acid residues. The starting inhibitor was ethyl-3-phenoxybenzyl-butylphosphonate, which had IC50 value of 2.0 μM in mycolyltransferase inhibition assay. Our search from more than 34 million compounds from public libraries yielded 49 compounds. Subsequently, selection was restricted to compounds conforming to the Lipinski rule of five and exhibiting hydrogen bonding to any of the amino acid residues in the active site pocket of all three proteins of antigen 85A, 85B, and 85C. Finally, we selected those ligands which were ranked top in the table with other known decoys in all the docking results. The compound NIH415032 from tuberculosis antimicrobial acquisition and coordinating facility was further examined using molecular dynamics simulations for 10 ns. These results showed that the binding is stable, although some of the hydrogen bond atom pairs varied through the course of simulation. The NIH415032 has antitubercular properties with IC90 at 20 μg/ml (53.023 μM). These results will be helpful to the medicinal chemists for developing new antitubercular molecules for testing.